Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development
PDF) The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Media
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged
Untitled
Haematologica, Volume 105, Issue 3 by Haematologica - Issuu
Vol. 102 No. 6 (2017): June, 2017 | Haematologica
Haematologica, Volume 104, Issue 10 by Haematologica - Issuu
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease | Haematologica
Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy - Chow - 2019 - American Journal of Hematology - Wiley Online Library
PDF) Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia
Untitled
Haematologica, Volume 106, Issue 5 by Haematologica - Issuu
Haematologica, Volume 106, Issue 11 by Haematologica - Issuu
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques: Molecular Therapy
Untitled
High‐level induction of fetal haemoglobin by pomalidomide in β‐thalassaemia/HbE erythroid progenitor cells - Khamphikham - 2020 - British Journal of Haematology - Wiley Online Library
Haematologica, Volume 105, issue 2 by Haematologica - Issuu
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
Haematologica, Volume 102, issue 10 by Haematologica - Issuu
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment | Blood Cancer Journal
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
Labile plasma iron levels predict survival in patients with lower-risk Myelodysplastic syndromes
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
